Magnetic Resonance Imaging (MRI)

MRI creates images from the magnetic resonance created in hydrogen atoms when they are polarized and an electromagnetic pulse is used to knock them off axis. This section includes MR analysis software, MRI scanners, gadolinium contrast agents and related magnetic resonance imaging accessories.

Figure 1. Left: Fetal brain post-intrauterine alcohol exposure in fetus between 25 and 29 gestational weeks. Note the smooth cortex in frontoparietal and temporal lobes. Right: Brain of matched healthy control case in fetus between 25 and 28 gestational weeks. The superior temporal sulcus is already bilaterally formed (red arrows) and appears deeper on the right hemisphere than on the left.
News | Pediatric Imaging
Drinking During Pregnancy Changes Baby’s Brain Structure

November 22, 2022 — A new MRI study revealed that consumption of alcohol even in low to moderate amounts during ...

Time November 22, 2022
arrow
Simulations by Rice University engineers have revealed details about the molecular interactions between gadolinium contrast agents used in MRI scans and their liquid environment. In this model, green gadolinium is surrounded by blue chelate ions, themselves surrounded by water (gray oxygen and red hydrogen atoms). Thiago Pinheiro dos Santos/Rice University
News | Magnetic Resonance Imaging (MRI)
Rice Refines Analysis of MRI Contrast Agents

November 21, 2022 — You can keep your best guesses. Engineers at Rice University’s George R. Brown School of Engineering ...

Time November 21, 2022
arrow
Figure 1. Group analysis on susceptibility-weighted imaging exhibiting higher susceptibility-weighted imaging values in the COVID group when compared to healthy controls. Three significant clusters were found primarily in the white matter regions of the pre-frontal cortex and in the brainstem. The clusters (a) and (b) are observed bilaterally in the cerebral white matter near the orbitofrontal gyrus, whereas (c) lies in the midbrain region.
News | Magnetic Resonance Imaging (MRI)
MRI Reveals Significant Brain Abnormalities Post-COVID

November 21, 2022 — Using a special type of MRI, researchers have uncovered brain changes in patients up to six months ...

Time November 21, 2022
arrow
71-year-old woman at high-risk for HCC due to chronic hepatitis B. Patient underwent CEUS using perfluorobutane. (A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase (48 seconds) shows corresponding early washout (arrow). (C) CEUS image in late phase (2 minutes) shows corresponding late and mild washout (arrow). (D) CEUS image in Kupffer phase (15 minutes) shows marked Kupffer defect (arrow). Patie
News | Magnetic Resonance Imaging (MRI)
CEUS With Perfluorobutane Diagnoses High-Risk HCC

November 17, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Time November 17, 2022
arrow
Enhanced offering gives hospitals flexibility to automate scan sequences from leading vendors into one scan protocol
News | Magnetic Resonance Imaging (MRI)
HeartVista, Siemens Healthineers Sign Commercial Agreement to Bring AI-Driven Image Acquisition to Hospital MRI Scanners

November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in ...

Time November 17, 2022
arrow
The Radiological Society of North America’s (RSNA) Quantitative Imaging Biomarkers Alliance (QIBA) and CaliberMRI, an industry leader in standardization of magnetic resonance imaging (MRI), announced the successful grant of Conformance Certification to NHS Greater Glasgow and Clyde (NHS GGC).
News | RSNA
CaliberMRI, Inc. and RSNA’s QIBA Announce First Conformance Certification for Diffusion-Weighted MRI

November 7, 2022 — The Radiological Society of North America’s (RSNA) Quantitative Imaging Biomarkers Alliance (QIBA) ...

Time November 07, 2022
arrow
News | Radiation Therapy
ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy

November 2, 2022 — ViewRay, Inc. announced the launch of a phase III randomized controlled trial titled "Locally ...

Time November 02, 2022
arrow
Top trends boosting the industry expansion through 2028
Feature | Contrast Media | By Shankar Khatkale
Imaging Contrast Agents Global Market Outlook

According to a recent study from market research firm Graphical Research, the global imaging agents market size is set ...

Time November 02, 2022
arrow
The Exablate Neuro is compatible with the Siemens Healthineers Magnetom Skyra, Prisma and Prisma Fit scanners. Exablate Neuro uses focused ultrasound for treatments deep within the brain with no surgical incisions.
Feature | Ultrasound Imaging | By Adil Khan
A Primer on High-intensity Focused Ultrasound Therapy

Ultrasound has the potential to interact mechanically and thermally with human tissue, and can even penetrate deep into ...

Time November 01, 2022
arrow
The Academy for Radiology & Biomedical Imaging Research (The Academy) and the Quantitative Imaging Biomarkers Alliance (QIBA) announce the recipients of their inaugural Academy Council of Early Career Investigators in Imaging (CECI²) & QIBA Fellowship
News | Radiology Imaging
The Academy and QIBA Announce Inaugural Fellowship Recipients

October 31, 2022 — The Academy for Radiology & Biomedical Imaging Research (The Academy) and the Quantitative Imaging ...

Time October 31, 2022
arrow
Lasting lung damage is persistently being seen, and studied, using MRI technology in children and teens with long COVID
Feature | Coronavirus (COVID-19) | By Melinda Taschetta-Millane
Long COVID Syndrome in Children and Teens

According to the American Academy of Pediatrics, as of October 6th, over 14.8 million children are reported to have ...

Time October 31, 2022
arrow
Clinical outcome oral presentations on SMART Pancreas and MIRAGE prostate studies Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Radiation Therapy
MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022

October 21, 2022 — ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRIdian MRI-Guided Radiation Therapy ...

Time October 21, 2022
arrow
FDA 510(k) clearance for AI-enabled Philips MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy application expands range of MR-only workflows
News | Magnetic Resonance Imaging (MRI)
Philips Advances MR Radiotherapy Imaging and Simulation for Head and Neck Cancers

October 20, 2022 — Royal Philips, a global leader in health technology, announced two new advances in MR-only workflows ...

Time October 20, 2022
arrow
54-year-old with pathologically confirmed inflammatory adenoma in left lobe that underwent evaluation by gadoxetate disodium-enhanced MRI. Axial T1-weighted fat-saturated precontrast image shows isointensity to liver of adenoma (arrow). Axial arterial-phase postcontrast image shows hyperintensity to liver (arrow). Axial portal-venous phase postcontrast image shows hyperintensity to liver (arrow). Axial hepatobiliary-phase postcontrast image shows hyperintensity to liver (arrow). Hepatobiliary-phase liver-to
News | Magnetic Resonance Imaging (MRI)
Gadoxetate Disodium–Enhanced MRI Algorithm Identifies Hepatocellular Adenomas

October 12, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), findings on gadoxetate ...

Time October 12, 2022
arrow
Free-breathing phase-resolved functional lung (PREFUL) low-field MRI at 0.55T with calculated parameters at an axial plane after automatic registration to a mid-expiration position and lung parenchyma segmentation. From left to right, representative color-coded images of functional show ventilation defects (VDP, blue), perfusion defects (QDP, red), ventilation/perfusion (V/Q match, green), ventilation/perfusion defects (V/Q defect, purple) in a healthy control (upper row, 7-year-old male), a participant rec
Feature | Radiology Business
Top 10: September's Most-read Content

Here is a recap of what ITN viewers found most interesting during the month of September: 1. Lasting Lung Damage Seen in ...

Time October 03, 2022
arrow
Extending deep learning-based AIR Recon DL compatibility to 3D and PROPELLER has the potential to enable more confident patient diagnoses in MRI
News | Magnetic Resonance Imaging (MRI)
GE Healthcare’s AIR Recon DL Receives FDA Clearance of 3D and Motion-Insensitive Imaging Applications for Next-Level Image Quality and Patient Experience in MRI

October 3, 2022 — GE Healthcare announced US FDA 510(k) clearance of its breakthrough AIR Recon DL for 3D and PROPELLER ...

Time October 03, 2022
arrow
33-year-old patient (gestational age, 30 weeks and 6 days), without in utero opioid exposure, who underwent fetal MRI
News | Pediatric Imaging
MRI Findings in Opioid-Exposed Fetuses Show Smaller Brain Size

September 29, 2022 — According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR ...

Time September 29, 2022
arrow
The collection of whole-body repeat imaging scans of 60,000 UK Biobank participants will provide researchers with a unique set of longitudinal measures to understand the determinants and progression of disease in mid-to-later life.
News | Radiology Imaging
Public-Private Partnership Announces Ambitious Project to Create the World's Largest Longitudinal Imaging Dataset to Assess Disease Progression

September 27, 2022 — UK Biobank, the large-scale biomedical database and research resource, together with the Medical ...

Time September 27, 2022
arrow
Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Gadopiclenol Injection, a new, highly stable macrocyclic gadolinium-based contrast agent (GBCA), in partnership with Guerbet.. 
News | Contrast Media
Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol), a new macrocyclic GBCA for use in contrast-enhanced magnetic resonance imaging (MRI).
News | Contrast Media
Guerbet Announces FDA Approval of Elucirem (Gadopiclenol) for Use in Contrast-enhanced MRI

September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration ...

Time September 21, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now